Overview
Updated 14 Jul 2026
Ruben Mesa, MD, is President & Executive Director, Atrium Health Wake Forest Baptist Comprehensive Cancer Center. The public record shows 1,282 publications with 45,977 citations (h-index 97), centered on Hematology. It also documents an investigator role on 15 registered clinical trials, industry payments reported by 20 companies, 1 NIH-funded awards (2022–2026).
- Most recent indexed publication: 2026 · JCO oncology practice
- Top research focus: Hematology
- 15 registered trials on ClinicalTrials.gov
- Open Payments reporting from 20 companies
Generated from the cited public record · current as of 14 Jul 2026. Every fact links its source below.
Indications focusfrom trials led + research topics
Research focusOpenAlex concept fingerprint
Drugs & moleculesacross trials, industry payments and publications
Works withtrial sponsors and companies reporting payments
Scholarshipindexed output and impact (OpenAlex)
View publications ↓Distinct works indexed by OpenAlex, matched via ORCID; 52 in PubMed.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industrytrials, payments and federal funding
Public positionssourced statements on record
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →news.uthscsa.edu ↗
Clinical trials
Updated 14 Jul 2026
Listed as an investigator on 15 registered studies on ClinicalTrials.gov. The most recent:
- Selinexor and Pacritinib in JAK Inhibitor-naïve MF Patients With Cytopenias
Sponsor: John Mascarenhas
InvestigatorPhase 2Not, yet, recruitingNCT07447817 - Calm for Cancer Patients Receiving Chemotherapy
Sponsor: The University of Texas Health Science Center at San Antonio
InvestigatorWithdrawnNCT04345952 - Combined Ruxolitinib and Enasidenib in Patients With Accelerated/Blast-phase Myeloproliferative Neoplasm or Chronic-phase Myelofibrosis With an IDH2 Mutation
Sponsor: John Mascarenhas
InvestigatorPhase 2CompletedNCT04281498
Industry payments
Updated 14 Jul 2026
20 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- GlaxoSmithKline, LLC.Program year202512 payments$27,136openpaymentsdata.cms.gov ↗
- Merck Sharp & Dohme LLCProgram year20254 payments
- Sumitomo Pharma America, Inc.Program year20251 payment
NIH funding
Updated 14 Jul 2026
1 NIH research award on record, funded 2022–2026 per NIH RePORTER. The latest:
Publications
Updated 14 Jul 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
Contact
An office address from a public listing. This research profile has no federal registry record to draw from.
Office address
Medical Center Boulevard, 3rd Floor, Winston-Salem, NC 27157
Background & recognition
Updated 14 Jul 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Educationdegrees and training on record
- MD
Mayo Clinic College of Medicine and Science
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →atriumhealth.org ↗ - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →wakehealth.edu ↗
- Board certified
Internal Medicine and Hematology (American Board of Internal Medicine)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →atriumhealth.org ↗
Editorial & leadership rolesjournal and society appointments
- President & Executive Director
Atrium Health Wake Forest Baptist Comprehensive Cancer Center (also Atrium Health Levine Cancer)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →atriumhealth.org ↗ - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →wakehealth.edu ↗
- Editor-in-Chief
Current Hematology Malignancy Reports
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →expertperspectives.com ↗
Awards & honorshonors on the public record
- 2025 ASH Ernest Beutler Lecture and Prize (American Society of Hematology)
for contributions to myeloproliferative neoplasm research including development of the MPN-SAF/MSAF patient-reported outcome tools
2025verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →oncodaily.com ↗ - 2024 Distinguished Alumnus
University of Illinois Urbana-Champaign College of Liberal Arts and Sciences
2024provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →aaci-cancer.org ↗ - provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →aaci-cancer.org ↗
Secondary affiliationsappointments beyond the home institution
- Wake Forest University School of Medicine
Vice Dean for Cancer Programs; Charles L. Spurr, MD Professor of Internal Medicine
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →wakehealth.edu ↗ - American Cancer Society
Board of Directors
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →cancer.org ↗ - provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →cancer.org ↗
Media & interviewspress, podcasts and appearances
- ASCO Post video (EHA 2021 Virtual Congress): myelofibrosis
transfusion independence, and momelotinib
2021verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ascopost.com ↗ - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →youtube.com ↗
- OncLive On Air podcast with Aaron Gerds
MD, management strategies and emerging agents in myelofibrosis
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →onclive.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Online presence
Updated 14 Jul 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accountspublic accounts run by this person
- Doximity
doximity.com/pub/ruben-mesa-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - LinkedIn
linkedin.com/in/ruben-mesa-md-0b94425
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗
Mentions by otherswhere others cite or feature them
- Other
bloodcancerunited.org/person/ruben-mesa-md-facp
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →bloodcancerunited.org ↗ - Other
empoweredpatientradio.com/breakthrough-treatment-for-myelofibrosis-changes-care-options-with-dr-ruben-mesa-atrium-health
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →empoweredpatientradio.com ↗ - Other
mpnresearchfoundation.org/news/qa-with-dr-ruben-mesa
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mpnresearchfoundation.org ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this specialty yet.